HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Megan Quimby Selected Research

Alzheimer Disease (Alzheimer's Disease)

5/2024Using explainable artificial intelligence to identify linguistic biomarkers of amyloid pathology in primary progressive aphasia.
1/2019Visual cognition in non-amnestic Alzheimer's disease: Relations to tau, amyloid, and cortical atrophy.
10/2018Flortaucipir tau PET imaging in semantic variant primary progressive aphasia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Megan Quimby Research Topics

Disease

5Primary Progressive Aphasia
05/2024 - 01/2017
5Atrophy
04/2024 - 01/2017
3Alzheimer Disease (Alzheimer's Disease)
05/2024 - 10/2018
2Cognitive Dysfunction
05/2024 - 01/2024
1Dementia (Dementias)
01/2024
1Tauopathies
10/2018
1Frontotemporal Lobar Degeneration (Degeneration, Frontotemporal Lobar)
10/2018

Drug/Important Bio-Agent (IBA)

5Amyloid (Amyloid Fibrils)IBA
05/2024 - 10/2018
2Biomarkers (Surrogate Marker)IBA
05/2024 - 01/2024
1Amyloid beta-PeptidesIBA
05/2024
1BuffersIBA
01/2021
1DNA-Binding Proteins (DNA Binding Protein)IBA
10/2018
17- (6- fluoropyridin- 3- yl)- 5H- pyrido(4,3- b)indoleIBA
10/2018
1N 30IBA
01/2017